Roles of genetic variants in three channelopathy genes—ABCC8, ATP13A3, and KCNK3—have been validated in multiple independent studies, and explain ~2.7% of PAH cases. The gene discussed is ATP13A3; the disease is pulmonary arterial hypertension.